Stay updated on Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    A top-level Locations section was added listing California, Massachusetts, New York, North Carolina, Texas, and Utah. The previous per-state location subsections (California Locations, Massachusetts Locations, New York Locations, North Carolina Locations, Texas Locations, Utah Locations) were removed.
    Difference
    0.7%
    Check dated 2025-12-23T21:28:16.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Publications now indicate that PubMed entries are automatically filled in from PubMed and may not relate to the study, and the revision label was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:20:29.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    A government funding operating status notice was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:11:08.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    No additions or deletions are visible on the Study Details page. The content continues to present the Pembrolizumab +/- Bevacizumab for Recurrent GBM study details.
    Difference
    0.3%
    Check dated 2025-11-03T21:03:57.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    3%
    Check dated 2025-10-06T05:33:00.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.
    Difference
    0.1%
    Check dated 2025-09-29T03:06:01.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page.